Location History:
- Calabass, CA (US) (2016)
- Calabasas, CA (US) (2010 - 2019)
Company Filing History:
Years Active: 2010-2019
Title: Innovations of Robin Farias-Eisner
Introduction
Robin Farias-Eisner is a prominent inventor based in Calabasas, California. He has made significant contributions to the field of medical research, particularly in the treatment and prevention of pro-inflammatory conditions. With a total of seven patents to his name, Farias-Eisner's work has the potential to impact various health conditions significantly.
Latest Patents
Farias-Eisner's latest patents include innovative approaches to using HDL-related molecules for treating and preventing pro-inflammatory conditions. These patents describe molecules and compositions that can prevent UV-induced cell death and oxidative stress in skin cells. They also demonstrate the ability to inhibit tumor growth and development in various cancers. Additionally, HDL-related molecules can be utilized as oral supplements to prevent or treat pro-inflammatory skin conditions and systemic issues, including Alzheimer's disease and different types of cancers. Another notable patent focuses on compositions and methods for treating gynecologic cancers, where ApoA-1 has been shown to inhibit cancer cell proliferation and reduce tumor size in mouse models of ovarian cancer.
Career Highlights
Farias-Eisner is affiliated with the University of California, where he continues to advance his research and innovations. His work is characterized by a commitment to developing effective treatments for serious health conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Farias-Eisner collaborates with esteemed colleagues, including Srinivasa T Reddy, to further enhance the impact of his research. Their combined expertise contributes to the development of groundbreaking solutions in the medical field.
Conclusion
Robin Farias-Eisner's innovative work in the realm of HDL-related molecules and cancer treatment exemplifies the potential of scientific research to transform healthcare. His contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.